Work Begins on Two NASA Projects

Posted Apr 27 2016 by with Comments Off on Work Begins on Two NASA Projects

A second phase Small Business Innovative Research (SBIR) grant from NASA has been awarded InnovaPrep to continue the work done during the Phase I project, which showed the feasibility adapting the InnovaPrep bio-concentration technology to work in a microgravity environment.  The developed system is slated for use aboard the International Space Station (ISS) for the purpose of monitoring the safety of the ISS water supply http://sbir.gsfc.nasa.gov/SBIR/abstracts/15/sbir/phase2/SBIR-15-2-H3.01-9921.html

In addition, a new Phase I NASA project has been awarded InnovaPrep for Devices and Methods for Collection and Concentration of Air and Surface Samples for Improved Detection.   This project builds on current collection and concentration technologies utilizing the company’s patented wet foam elution process. http://sbir.nasa.gov/SBIR/abstracts/16/sbir/phase1/SBIR-16-1-H3.01-7134.html

CTO to Present Poster at Upcoming EPA’s Recreational Waters Conference

Posted Mar 17 2016 by with 0 Comments

Andy Page, President and Chief Technology Officer will be presenting a poster at the upcoming EPA’s Recreational Waters Conference April 12-15th in New Orleans. The poster addresses rapid detection of fecal indicator bacteria in recreational waters . Continue…

Microbiological Monitoring for Pharma Applications

Posted Feb 23 2016 by with Comments Off on Microbiological Monitoring for Pharma Applications

Rapid analytical methods are becoming an essential part of a complete program for Microbiological Control and Monitoring of Aseptic Processing Environments, however, widespread use of these technologies is long overdue.  The ability to reduce ”time-to-detection” from days to same-shift will provide widespread benefits through reduction in holding times, recalls, and incidence of harm.  In addition, the adoption of rapid methods allow new sampling regimes to be more meaningful, effective, and informative for corrective action. These are significant changes that will make pharmaceutical products safer and protect the industry from losses in revenue.

To fully realize the promise of next-generation rapid analytical methods, new collection and sample prep technologies will also need to be adopted.  more